1. Home
  2. CIF vs SLGL Comparison

CIF vs SLGL Comparison

Compare CIF & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CIF
  • SLGL
  • Stock Information
  • Founded
  • CIF 1988
  • SLGL 1997
  • Country
  • CIF United States
  • SLGL Israel
  • Employees
  • CIF N/A
  • SLGL N/A
  • Industry
  • CIF Trusts Except Educational Religious and Charitable
  • SLGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • CIF Finance
  • SLGL Health Care
  • Exchange
  • CIF Nasdaq
  • SLGL Nasdaq
  • Market Cap
  • CIF 31.5M
  • SLGL 30.9M
  • IPO Year
  • CIF N/A
  • SLGL 2018
  • Fundamental
  • Price
  • CIF $1.75
  • SLGL $0.61
  • Analyst Decision
  • CIF
  • SLGL Strong Buy
  • Analyst Count
  • CIF 0
  • SLGL 2
  • Target Price
  • CIF N/A
  • SLGL $5.00
  • AVG Volume (30 Days)
  • CIF 43.9K
  • SLGL 107.1K
  • Earning Date
  • CIF 01-01-0001
  • SLGL 03-12-2025
  • Dividend Yield
  • CIF 10.11%
  • SLGL N/A
  • EPS Growth
  • CIF N/A
  • SLGL N/A
  • EPS
  • CIF N/A
  • SLGL N/A
  • Revenue
  • CIF N/A
  • SLGL $11,707,000.00
  • Revenue This Year
  • CIF N/A
  • SLGL $772.97
  • Revenue Next Year
  • CIF N/A
  • SLGL N/A
  • P/E Ratio
  • CIF N/A
  • SLGL N/A
  • Revenue Growth
  • CIF N/A
  • SLGL 869.93
  • 52 Week Low
  • CIF $1.47
  • SLGL $0.33
  • 52 Week High
  • CIF $1.77
  • SLGL $1.65
  • Technical
  • Relative Strength Index (RSI)
  • CIF 53.38
  • SLGL 39.08
  • Support Level
  • CIF $1.73
  • SLGL $0.55
  • Resistance Level
  • CIF $1.76
  • SLGL $0.78
  • Average True Range (ATR)
  • CIF 0.02
  • SLGL 0.09
  • MACD
  • CIF 0.00
  • SLGL -0.02
  • Stochastic Oscillator
  • CIF 75.00
  • SLGL 17.14

About CIF MFS Intermediate High Income Fund

Mfs Intermediate High Income Fund is a United States based diversified closed-end management investment company. Its investment objective is to seek high current income but may also consider capital appreciation. The fund invests a majority of its net assets, including borrowings for investment purposes, in high-income debt instruments. Its portfolio of investments includes investment grade corporate bonds, government securities and other securities.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.

Share on Social Networks: